actinomycin D

(redirected from Cosmegen)
Also found in: Medical.

actinomycin D

References in periodicals archive ?
Other important products acquired in the acquisition are NeoProfen (ibuprofen lysine injection) and Indocin IV (indomethacin injection), which is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants, and Cosmegen (dactinomycin for injection), used mainly in the treatment of three rare cancers.
The current competition in the global Ewing's sarcoma therapeutics market is weak, as there is only one approved drug, Cosmegen (dactinomycin), which is no longer in use due to its low safety and efficacy profiles.
Dactinomycin was approved earlier this year and is AP rated and equivalent to Cosmegen (Lundbeck Inc.